Evolving Landscape of Multiple Sclerosis in India: Challenges in the Management
- PMID: 30122834
- PMCID: PMC6073961
- DOI: 10.4103/aian.AIAN_33_18
Evolving Landscape of Multiple Sclerosis in India: Challenges in the Management
Abstract
Multiple sclerosis (MS) is a chronic neurological disease which often leads to disability. The complex etiology and progressive nature pose challenges in the management of patients with MS, particularly in developing countries like India. Lack of data on prevalence further complicates estimation of the magnitude of MS in India. There are various other challenges associated with management of patients with MS due to which the therapy is utilized by only a small segment of population in India. This article encapsulates the gaps and challenges in the management of patients with MS and presents suggestions and recommendations of the members of advisory boards held to discuss these challenges. The advisory board members suggested that an early diagnosis of MS and an early initiation of treatment are essential to achieve better results for tackling MS-related challenges. In addition, awareness and education about MS among people, regular training to physicians, emphasis on the use of revised 2010 McDonald criteria, and utilization of advanced diagnostic modalities in magnetic resonance imaging would help to achieve desirable as well as effective therapeutic outcomes. Further, access to an easy-to-use therapy delivery system could also be beneficial in attaining an adequate treatment adherence and related health benefits.
Keywords: Adherence; challenges; diagnosis; multiple sclerosis; referral; treatment.
Conflict of interest statement
The authors received honoraria as consultants for Merck Ltd, Mumbai, India, for these advisory board meetings. Dr. Harshal and Dr. Priti are employees of Merck Ltd., Mumbai, India, an affiliate of Merck KGaA (Darmstadt, Germany).[72]
Figures
Similar articles
-
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges.J Clin Med. 2023 Jun 26;12(13):4274. doi: 10.3390/jcm12134274. J Clin Med. 2023. PMID: 37445309 Free PMC article. Review.
-
Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India.Int J Endocrinol. 2016;2016:2967578. doi: 10.1155/2016/2967578. Epub 2016 Oct 27. Int J Endocrinol. 2016. PMID: 27867396 Free PMC article. Review.
-
Sepsis Care Pathway 2019.Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019. Qatar Med J. 2019. PMID: 31763206 Free PMC article.
-
[A current view on the MRI diagnosis of multiple sclerosis: an update of 2016 revised MRI criteria].Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):66-73. doi: 10.17116/jnevro20171172266-73. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28617364 Russian.
-
Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.Clin Neurol Neurosurg. 2016 Apr;143:51-64. doi: 10.1016/j.clineuro.2016.02.001. Epub 2016 Feb 4. Clin Neurol Neurosurg. 2016. PMID: 26896783
Cited by
-
Overtime Challenges of Diagnosis and Treatment in Two Pediatric Patients with Extensive Cerebral Tumefactive Lesions Indicative of Baló's Type Multiple Sclerosis.Children (Basel). 2025 May 14;12(5):630. doi: 10.3390/children12050630. Children (Basel). 2025. PMID: 40426809 Free PMC article.
-
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges.J Clin Med. 2023 Jun 26;12(13):4274. doi: 10.3390/jcm12134274. J Clin Med. 2023. PMID: 37445309 Free PMC article. Review.
References
-
- Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221–31. - PubMed
-
- Jobin C, Larochelle C, Parpal H, Coyle PK, Duquette P. Gender issues in multiple sclerosis: An update. Womens Health (Lond) 2010;6:797–820. - PubMed
-
- Myhr KM. Diagnosis and treatment of multiple sclerosis. Acta Neurol Scand Suppl. 2008;188:12–21. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources